Creative Medical Tech Files 8-K with Corporate Updates
Ticker: CELZ · Form: 8-K · Filed: Dec 26, 2024 · CIK: 1187953
| Field | Detail |
|---|---|
| Company | Creative Medical Technology Holdings, INC. (CELZ) |
| Form Type | 8-K |
| Filed Date | Dec 26, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update, financials
Related Tickers: CMED
TL;DR
CMED filed an 8-K on Dec 26 for Dec 19 events - expect corporate updates and financial docs.
AI Summary
Creative Medical Technology Holdings, Inc. filed an 8-K on December 26, 2024, reporting events that occurred on December 19, 2024. The filing indicates changes related to amendments to articles of incorporation or bylaws, submission of matters to a vote of security holders, and financial statements and exhibits. The company is incorporated in Nevada and its principal executive offices are located in Phoenix, AZ.
Why It Matters
This 8-K filing signals potential corporate governance changes or significant business events that could impact the company's structure, operations, or financial reporting.
Risk Assessment
Risk Level: medium — 8-K filings can signal significant corporate events, but the specific details of the changes are not yet fully elaborated in this initial summary.
Key Players & Entities
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (company) — Registrant
- December 19, 2024 (date) — Earliest event reported
- December 26, 2024 (date) — Date of report
- Phoenix, AZ (location) — Principal executive offices
FAQ
What specific amendments were made to the articles of incorporation or bylaws?
The filing indicates that amendments to articles of incorporation or bylaws were submitted, but the specific details of these amendments are not provided in this summary.
What matters were submitted to a vote of security holders?
The filing states that matters were submitted to a vote of security holders, but the nature of these matters is not specified in this summary.
What financial statements and exhibits are included in this filing?
The filing lists 'Financial Statements and Exhibits' as an item information, but the specific content of these documents is not detailed here.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on December 19, 2024.
What is the company's principal executive office address?
The company's principal executive offices are located at 211 E Osborn Road, Phoenix, AZ 85012.
Filing Stats: 968 words · 4 min read · ~3 pages · Grade level 13 · Accepted 2024-12-26 17:00:20
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share CELZ The Nasdaq Stock Mar
Filing Documents
- celz_8k.htm (8-K) — 33KB
- celz_ex31.htm (EX-3.1) — 2KB
- celz_ex32.htm (EX-3.2) — 1KB
- celz_ex33.htm (EX-3.3) — 1KB
- celz_ex32img1.jpg (GRAPHIC) — 260KB
- celz_ex33img1.jpg (GRAPHIC) — 260KB
- celz_ex31img3.jpg (GRAPHIC) — 129KB
- celz_ex31img1.jpg (GRAPHIC) — 248KB
- celz_ex31img2.jpg (GRAPHIC) — 184KB
- 0001477932-24-008314.txt ( ) — 1648KB
- celz-20241219.xsd (EX-101.SCH) — 6KB
- celz-20241219_lab.xml (EX-101.LAB) — 14KB
- celz-20241219_cal.xml (EX-101.CAL) — 1KB
- celz-20241219_pre.xml (EX-101.PRE) — 9KB
- celz-20241219_def.xml (EX-101.DEF) — 2KB
- celz_8k_htm.xml (XML) — 4KB
03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On December 19, 2024, the stockholders of Creative Medical Technology Holdings, Inc. (the "Company") approved an amendment to the Company's Articles of Incorporation to increase the number of authorized shares of common stock from 5,000,000 to 25,000,000. The Company filed a Certificate of Amendment with the Secretary of State of the State of Nevada on December 19, 2024 to effect such increase. The Certificate of Amendment has been filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated by reference herein. In addition, on December 20, 2024, following the approval of the Board of Directors of the Company, the Company filed with the Secretary of State of the State of Nevada (i) a Certificate of Withdrawal of Certificate of Designation with respect to the Company's Series A Preferred Stock, and (ii) a Certificate of Withdrawal of Certificate of Designation with respect to the Company's Series B Preferred Stock. At the time of such filings, the Company did not have any outstanding shares of Series A Preferred Stock or Series B Preferred Stock.
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On December 19, 2024, the Company held a Special Meeting of Stockholders (the "Special Meeting") to consider and vote on proposals for (i) the approval of an amendment to the Company's Articles of Incorporation increasing the number of the Company's authorized shares of common stock from 5,000,000 shares to 25,000,000 shares ("Proposal I" or the "Share Increase Proposal"); and (ii) the approval of the exercise in full of warrants to purchase an aggregate of 837,104 shares of the Company's common stock (the "Investor Warrants") issued in a private placement on October 23, 2024 ("Proposal II"). Each of the foregoing proposals is described in more detail in the definitive proxy statement for the Special Meeting filed with the Securities and Exchange Commission on November 4, 2024. Stockholders holding an aggregate of 1,1071,414 shares of common stock and one share of Series B Preferred Stock, representing 61.3% of the outstanding shares of the Company's common stock as of the record date, and which constituted a quorum, were present in person or represented by proxy at the Special Meeting. Pursuant to the Certificate of Designation designating the Series B Preferred Stock (i) the share of Series B Preferred Stock has no voting rights other than the right to 100,000,000 votes on the Share Increase Proposal, and (ii) such votes were automatically cast both for and against the Share Increase Proposal in the same proportion as the votes cast by shares of the Company's common stock on such proposal. The results of the voting at the Special Meeting are presented below. Proposal I - The Share Increase Proposal was approved as follows: For Against Abstain Broker Non-Votes Common Stock 715,913 394,445 3,649 N/A B Preferred Stock 64,264,677 35,407,767 327,556 N/A Total 64,980,590 35,802,212 331,205 N/A Proposal II - The exercise in full of the Investor Warrants was approved as follows: Fo
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . 3.1 Certificate of Amendment to Articles of Incorporation of Creative Medical Technology Holdings, Inc., as filed with the Secretary of State of the State of Nevada on December 19, 2024 3.2 Certificate of Certificate of Withdrawal of Certificate of Designation of Series A Preferred Stock, as filed with the Secretary of State of the State of Nevada on December 20, 2024 3.3 Certificate of Certificate of Withdrawal of Certificate of Designation of Series B Preferred Stock, as filed with the Secretary of State of the State of Nevada on December 20, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Creative Medical Technology Holdings, Inc. Date: December 26, 2024 By: /s/ Timothy Warbington Timothy Warbington, Chief Executive Officer 3